ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical ...

Two types of COVID-19 tests, the rapid antigen test and the polymerase chain reaction (PCR) test, are available in the United States. The PCR typically relies on lab testing and is still considered ...

New COVID-19 restrictions for international travel and other activities are fueling consumer demand for highly accurate polymerase chain reaction, or PCR, tests with rapid turnaround times. Some ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hilary Brueck Every time Hilary publishes a story, you’ll get an alert straight to your inbox!

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...

July 25 (UPI) --Scientists at Columbia University unveiled research Monday they said is "a step closer" toward bringing polymerase chain reaction, known as PCR, testing for COVID-19 and other viruses ...